| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 137 | 2024 | 8986 | 5.260 |
Why?
|
| Glioblastoma | 84 | 2024 | 3484 | 5.080 |
Why?
|
| Glioma | 71 | 2024 | 3420 | 4.640 |
Why?
|
| Astrocytoma | 25 | 2023 | 775 | 2.190 |
Why?
|
| Meningioma | 14 | 2022 | 1221 | 1.380 |
Why?
|
| Meningeal Neoplasms | 15 | 2022 | 1249 | 1.370 |
Why?
|
| Oligodendroglia | 12 | 2020 | 536 | 1.300 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 15 | 2019 | 1139 | 1.100 |
Why?
|
| Mutation | 73 | 2024 | 29932 | 1.090 |
Why?
|
| PTEN Phosphohydrolase | 11 | 2020 | 1115 | 0.990 |
Why?
|
| Central Nervous System Neoplasms | 8 | 2024 | 916 | 0.970 |
Why?
|
| Isocitrate Dehydrogenase | 18 | 2024 | 929 | 0.940 |
Why?
|
| Dacarbazine | 14 | 2022 | 560 | 0.930 |
Why?
|
| DNA Copy Number Variations | 11 | 2022 | 2013 | 0.910 |
Why?
|
| Comparative Genomic Hybridization | 13 | 2017 | 473 | 0.890 |
Why?
|
| Proto-Oncogene Proteins B-raf | 16 | 2024 | 2053 | 0.890 |
Why?
|
| Medulloblastoma | 9 | 2024 | 679 | 0.880 |
Why?
|
| Neoplasm Recurrence, Local | 20 | 2024 | 9276 | 0.820 |
Why?
|
| Antineoplastic Agents, Alkylating | 10 | 2022 | 618 | 0.820 |
Why?
|
| Oligodendroglioma | 11 | 2024 | 279 | 0.790 |
Why?
|
| Nerve Tissue Proteins | 12 | 2014 | 4407 | 0.770 |
Why?
|
| Single-Cell Analysis | 12 | 2024 | 2380 | 0.770 |
Why?
|
| Tumor Suppressor Protein p53 | 16 | 2023 | 2919 | 0.750 |
Why?
|
| Aminopyridines | 4 | 2019 | 564 | 0.710 |
Why?
|
| Morpholines | 4 | 2019 | 583 | 0.670 |
Why?
|
| Oncogene Proteins, Fusion | 11 | 2022 | 1596 | 0.660 |
Why?
|
| Cerebellar Neoplasms | 6 | 2024 | 587 | 0.660 |
Why?
|
| Phosphatidylinositol 3-Kinase | 2 | 2023 | 126 | 0.660 |
Why?
|
| High-Throughput Nucleotide Sequencing | 18 | 2024 | 3616 | 0.650 |
Why?
|
| Neural Stem Cells | 7 | 2020 | 884 | 0.640 |
Why?
|
| Pineal Gland | 4 | 2019 | 157 | 0.640 |
Why?
|
| Brain Stem Neoplasms | 6 | 2022 | 190 | 0.600 |
Why?
|
| Genomics | 19 | 2024 | 5794 | 0.600 |
Why?
|
| Antineoplastic Agents | 19 | 2023 | 13630 | 0.590 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 2414 | 0.580 |
Why?
|
| Cell Lineage | 17 | 2024 | 2533 | 0.580 |
Why?
|
| Stem Cells | 9 | 2014 | 3523 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 27 | 2020 | 8515 | 0.550 |
Why?
|
| Oncogenes | 10 | 2022 | 1220 | 0.550 |
Why?
|
| Trans-Activators | 4 | 2019 | 2860 | 0.550 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.530 |
Why?
|
| Histones | 12 | 2023 | 2583 | 0.530 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2023 | 2864 | 0.520 |
Why?
|
| Central Nervous System | 5 | 2022 | 1334 | 0.520 |
Why?
|
| Hedgehog Proteins | 5 | 2015 | 769 | 0.520 |
Why?
|
| Humans | 252 | 2024 | 760621 | 0.480 |
Why?
|
| Cell Line, Tumor | 39 | 2024 | 16939 | 0.470 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2022 | 4490 | 0.470 |
Why?
|
| Mice | 72 | 2024 | 81208 | 0.460 |
Why?
|
| Germinoma | 2 | 2022 | 132 | 0.460 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 9 | 2020 | 698 | 0.450 |
Why?
|
| DNA Methylation | 15 | 2023 | 4373 | 0.440 |
Why?
|
| Pinealoma | 3 | 2019 | 51 | 0.440 |
Why?
|
| Astrocytes | 12 | 2024 | 1338 | 0.430 |
Why?
|
| Molecular Targeted Therapy | 8 | 2024 | 2803 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2023 | 2828 | 0.410 |
Why?
|
| Rhabdoid Tumor | 3 | 2024 | 210 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 10 | 2020 | 4713 | 0.400 |
Why?
|
| Receptor, trkB | 3 | 2020 | 125 | 0.400 |
Why?
|
| Animals | 87 | 2024 | 167963 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 1 | 6 | 2019 | 635 | 0.390 |
Why?
|
| Genome, Human | 10 | 2020 | 4417 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2020 | 3604 | 0.390 |
Why?
|
| DNA Modification Methylases | 7 | 2022 | 209 | 0.390 |
Why?
|
| Triazoles | 4 | 2024 | 904 | 0.380 |
Why?
|
| Glutarates | 5 | 2023 | 244 | 0.370 |
Why?
|
| Cell Differentiation | 18 | 2024 | 11481 | 0.370 |
Why?
|
| Child | 58 | 2024 | 79806 | 0.370 |
Why?
|
| Ependymoma | 3 | 2020 | 320 | 0.350 |
Why?
|
| Gene Expression Profiling | 22 | 2021 | 9411 | 0.350 |
Why?
|
| Neurons | 10 | 2020 | 9426 | 0.350 |
Why?
|
| Forkhead Transcription Factors | 4 | 2022 | 1612 | 0.340 |
Why?
|
| Angiomatosis | 1 | 2009 | 46 | 0.320 |
Why?
|
| DNA Repair Enzymes | 6 | 2022 | 345 | 0.320 |
Why?
|
| Prognosis | 32 | 2024 | 29658 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2018 | 11712 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2019 | 5253 | 0.310 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2022 | 2802 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4573 | 0.310 |
Why?
|
| Hydrazines | 2 | 2024 | 224 | 0.310 |
Why?
|
| DNA Mutational Analysis | 11 | 2021 | 4107 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2019 | 79 | 0.310 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2020 | 367 | 0.300 |
Why?
|
| Gene Dosage | 6 | 2020 | 1218 | 0.300 |
Why?
|
| Retinal Neoplasms | 1 | 2009 | 146 | 0.300 |
Why?
|
| Xenograft Model Antitumor Assays | 11 | 2023 | 3584 | 0.290 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2821 | 0.290 |
Why?
|
| Mice, Nude | 12 | 2019 | 3607 | 0.290 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 670 | 0.290 |
Why?
|
| Glycoproteins | 2 | 2014 | 2208 | 0.280 |
Why?
|
| Male | 99 | 2024 | 359744 | 0.280 |
Why?
|
| Genome-Wide Association Study | 4 | 2017 | 12626 | 0.280 |
Why?
|
| Cell Proliferation | 20 | 2024 | 10446 | 0.270 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2013 | 267 | 0.270 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2019 | 114 | 0.260 |
Why?
|
| Neoplasms | 10 | 2024 | 22072 | 0.260 |
Why?
|
| Immunotherapy | 3 | 2020 | 4642 | 0.260 |
Why?
|
| Signal Transduction | 23 | 2020 | 23376 | 0.260 |
Why?
|
| Telomerase | 3 | 2023 | 746 | 0.260 |
Why?
|
| Female | 97 | 2024 | 391270 | 0.250 |
Why?
|
| Pituitary Neoplasms | 4 | 2017 | 1313 | 0.250 |
Why?
|
| Child, Preschool | 26 | 2024 | 42063 | 0.250 |
Why?
|
| Neoplastic Stem Cells | 5 | 2022 | 1347 | 0.240 |
Why?
|
| Tumor Microenvironment | 11 | 2023 | 3844 | 0.240 |
Why?
|
| Neoplasms, Experimental | 5 | 2020 | 1229 | 0.240 |
Why?
|
| Adult | 61 | 2024 | 219994 | 0.240 |
Why?
|
| Antigens, CD | 2 | 2014 | 4000 | 0.230 |
Why?
|
| Transcription Factors | 14 | 2024 | 12103 | 0.230 |
Why?
|
| RNA-Binding Proteins | 4 | 2017 | 1894 | 0.230 |
Why?
|
| Gene Fusion | 2 | 2017 | 354 | 0.220 |
Why?
|
| Histocytochemistry | 1 | 2024 | 700 | 0.220 |
Why?
|
| Adolescent | 37 | 2024 | 87810 | 0.220 |
Why?
|
| Quinazolines | 4 | 2015 | 1363 | 0.210 |
Why?
|
| Aneuploidy | 2 | 2021 | 551 | 0.210 |
Why?
|
| Proteoglycans | 1 | 2006 | 801 | 0.210 |
Why?
|
| Craniopharyngioma | 2 | 2017 | 277 | 0.210 |
Why?
|
| Indoles | 4 | 2015 | 1829 | 0.210 |
Why?
|
| Interneurons | 2 | 2020 | 591 | 0.210 |
Why?
|
| Embryo, Mammalian | 7 | 2020 | 1674 | 0.210 |
Why?
|
| Telencephalon | 1 | 2003 | 142 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2023 | 5643 | 0.200 |
Why?
|
| Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
| Neuroblastoma | 2 | 2022 | 1252 | 0.200 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2018 | 806 | 0.200 |
Why?
|
| Choriocarcinoma | 1 | 2022 | 121 | 0.200 |
Why?
|
| Ribonuclease III | 2 | 2022 | 279 | 0.200 |
Why?
|
| Piperidines | 3 | 2018 | 1650 | 0.200 |
Why?
|
| Gliosarcoma | 1 | 2022 | 113 | 0.200 |
Why?
|
| Epigenomics | 3 | 2023 | 936 | 0.200 |
Why?
|
| Cell Cycle | 6 | 2022 | 2934 | 0.200 |
Why?
|
| Middle Aged | 52 | 2021 | 220352 | 0.190 |
Why?
|
| Cerebrum | 3 | 2016 | 132 | 0.190 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 494 | 0.190 |
Why?
|
| Meninges | 1 | 2003 | 197 | 0.190 |
Why?
|
| Choristoma | 1 | 2003 | 207 | 0.190 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 1900 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2022 | 383 | 0.190 |
Why?
|
| Wilms Tumor | 1 | 2024 | 375 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2019 | 2506 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 4 | 2019 | 1484 | 0.190 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.180 |
Why?
|
| Transducin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Survival Rate | 13 | 2021 | 12808 | 0.180 |
Why?
|
| Sarcoma | 3 | 2022 | 1786 | 0.180 |
Why?
|
| Multigene Family | 3 | 2013 | 1077 | 0.180 |
Why?
|
| Retrospective Studies | 29 | 2024 | 80372 | 0.180 |
Why?
|
| Pathology, Clinical | 1 | 2024 | 375 | 0.180 |
Why?
|
| Neurogenesis | 3 | 2019 | 856 | 0.180 |
Why?
|
| Aged | 44 | 2021 | 169152 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2022 | 280 | 0.180 |
Why?
|
| Antigens | 1 | 2006 | 1447 | 0.180 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2014 | 286 | 0.180 |
Why?
|
| DNA Mismatch Repair | 2 | 2021 | 429 | 0.180 |
Why?
|
| Clinical Trials as Topic | 6 | 2024 | 8056 | 0.180 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 329 | 0.180 |
Why?
|
| Epigenesis, Genetic | 8 | 2022 | 3758 | 0.180 |
Why?
|
| Infant | 20 | 2024 | 36060 | 0.170 |
Why?
|
| MicroRNAs | 4 | 2019 | 3790 | 0.170 |
Why?
|
| Brain | 12 | 2022 | 26951 | 0.170 |
Why?
|
| Cell Cycle Proteins | 7 | 2024 | 3446 | 0.170 |
Why?
|
| Young Adult | 26 | 2022 | 58741 | 0.170 |
Why?
|
| Brain Edema | 2 | 2020 | 603 | 0.170 |
Why?
|
| Neuroglia | 2 | 2019 | 944 | 0.170 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2020 | 611 | 0.170 |
Why?
|
| Immunohistochemistry | 16 | 2020 | 11071 | 0.170 |
Why?
|
| Karyopherins | 2 | 2024 | 130 | 0.170 |
Why?
|
| Cell Size | 1 | 2021 | 624 | 0.170 |
Why?
|
| DNA Damage | 4 | 2022 | 2442 | 0.170 |
Why?
|
| Spinal Cord | 4 | 2016 | 1817 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 343 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2018 | 184 | 0.170 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2019 | 2049 | 0.170 |
Why?
|
| Chromosome Deletion | 3 | 2015 | 1387 | 0.170 |
Why?
|
| Zebrafish Proteins | 3 | 2012 | 1006 | 0.170 |
Why?
|
| DNA-Binding Proteins | 6 | 2012 | 9585 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 895 | 0.160 |
Why?
|
| Aged, 80 and over | 22 | 2021 | 58995 | 0.160 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2018 | 50 | 0.160 |
Why?
|
| Protein Folding | 1 | 2023 | 867 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2020 | 36290 | 0.160 |
Why?
|
| Testicular Neoplasms | 3 | 2015 | 801 | 0.160 |
Why?
|
| Dictionaries as Topic | 1 | 2018 | 11 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 6544 | 0.160 |
Why?
|
| Cell Enlargement | 1 | 2018 | 60 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2024 | 435 | 0.160 |
Why?
|
| Ganglioglioma | 1 | 2018 | 36 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2024 | 454 | 0.160 |
Why?
|
| Retina | 1 | 2009 | 2635 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 68 | 0.160 |
Why?
|
| Survival Analysis | 10 | 2023 | 10182 | 0.160 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 123 | 0.160 |
Why?
|
| Dexamethasone | 3 | 2020 | 1927 | 0.160 |
Why?
|
| Pyrroles | 2 | 2015 | 1137 | 0.160 |
Why?
|
| Carcinoma, Medullary | 1 | 2019 | 115 | 0.160 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 188 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 717 | 0.150 |
Why?
|
| Autopsy | 2 | 2019 | 1007 | 0.150 |
Why?
|
| Stathmin | 1 | 2018 | 70 | 0.150 |
Why?
|
| Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 1 | 2024 | 994 | 0.150 |
Why?
|
| Alleles | 5 | 2019 | 6898 | 0.150 |
Why?
|
| Mutagenesis | 2 | 2020 | 1234 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2008 | 52 | 0.150 |
Why?
|
| Neoplasm Transplantation | 6 | 2019 | 2014 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
| Epilepsy | 3 | 2024 | 3267 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2022 | 368 | 0.150 |
Why?
|
| Apoptosis | 10 | 2024 | 9501 | 0.150 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 515 | 0.150 |
Why?
|
| Transaminases | 1 | 2018 | 196 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2021 | 15789 | 0.150 |
Why?
|
| Pyridazines | 1 | 2019 | 200 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 786 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 2005 | 0.150 |
Why?
|
| Databases, Protein | 1 | 2019 | 388 | 0.150 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2017 | 34 | 0.140 |
Why?
|
| Cyclin G1 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Cell Survival | 9 | 2024 | 5797 | 0.140 |
Why?
|
| Azetidines | 1 | 2018 | 141 | 0.140 |
Why?
|
| Methionine | 2 | 2022 | 569 | 0.140 |
Why?
|
| Chromatin | 4 | 2022 | 2938 | 0.140 |
Why?
|
| Activin Receptors, Type I | 2 | 2016 | 136 | 0.140 |
Why?
|
| Azepines | 1 | 2019 | 330 | 0.140 |
Why?
|
| Disease Progression | 10 | 2021 | 13502 | 0.140 |
Why?
|
| Proteostasis Deficiencies | 1 | 2017 | 39 | 0.140 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 9530 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2019 | 347 | 0.140 |
Why?
|
| raf Kinases | 1 | 2017 | 118 | 0.140 |
Why?
|
| Vinblastine | 1 | 2018 | 487 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2017 | 279 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 22023 | 0.140 |
Why?
|
| Interleukin-12 | 1 | 2019 | 584 | 0.140 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2016 | 31 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2019 | 256 | 0.140 |
Why?
|
| Myelin Sheath | 3 | 2012 | 652 | 0.140 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2981 | 0.140 |
Why?
|
| Myxoma | 1 | 2017 | 114 | 0.130 |
Why?
|
| Genes, p53 | 2 | 2009 | 713 | 0.130 |
Why?
|
| Nuclear Proteins | 7 | 2024 | 5791 | 0.130 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2016 | 76 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2019 | 3602 | 0.130 |
Why?
|
| Glutamic Acid | 2 | 2019 | 1167 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2024 | 949 | 0.130 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 1388 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 1088 | 0.130 |
Why?
|
| Imidazolines | 1 | 2015 | 18 | 0.130 |
Why?
|
| Treatment Outcome | 20 | 2023 | 65017 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 3618 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1313 | 0.130 |
Why?
|
| Metformin | 1 | 2023 | 912 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 2448 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2024 | 1131 | 0.130 |
Why?
|
| Follow-Up Studies | 15 | 2020 | 39261 | 0.130 |
Why?
|
| Medical Tourism | 1 | 2016 | 52 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1245 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1697 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 854 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 193 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 772 | 0.130 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 210 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 9 | 2021 | 5785 | 0.130 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 224 | 0.130 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 2018 | 345 | 0.130 |
Why?
|
| Cohort Studies | 16 | 2022 | 41335 | 0.130 |
Why?
|
| Tissue Distribution | 3 | 2015 | 2262 | 0.120 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2015 | 32 | 0.120 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.120 |
Why?
|
| Peptides | 2 | 2019 | 4354 | 0.120 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 384 | 0.120 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 114 | 0.120 |
Why?
|
| Gossypol | 1 | 2014 | 23 | 0.120 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 3610 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2012 | 550 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1380 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 6131 | 0.120 |
Why?
|
| Kidney Neoplasms | 2 | 2024 | 4312 | 0.120 |
Why?
|
| Seizures | 4 | 2024 | 2917 | 0.120 |
Why?
|
| Cells, Cultured | 13 | 2018 | 18957 | 0.120 |
Why?
|
| Interferon-gamma | 2 | 2020 | 3157 | 0.120 |
Why?
|
| Oxadiazoles | 1 | 2014 | 94 | 0.120 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2016 | 148 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 491 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2017 | 2907 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 475 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10181 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 1998 | 0.120 |
Why?
|
| Point Mutation | 2 | 2017 | 1594 | 0.120 |
Why?
|
| Neoplasm Staging | 9 | 2015 | 11152 | 0.120 |
Why?
|
| Loss of Heterozygosity | 2 | 2014 | 659 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1520 | 0.110 |
Why?
|
| Software | 2 | 2021 | 4419 | 0.110 |
Why?
|
| DNA Helicases | 4 | 2024 | 854 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2013 | 1356 | 0.110 |
Why?
|
| Algorithms | 7 | 2019 | 13981 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1091 | 0.110 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 18137 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 796 | 0.110 |
Why?
|
| Imidazoles | 1 | 2019 | 1180 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 385 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 1007 | 0.110 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2014 | 223 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2014 | 200 | 0.110 |
Why?
|
| Epitopes | 1 | 2019 | 2503 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1355 | 0.110 |
Why?
|
| Disease-Free Survival | 8 | 2016 | 6828 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2015 | 2668 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2020 | 3615 | 0.110 |
Why?
|
| Gene Amplification | 2 | 2014 | 1085 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2020 | 977 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2019 | 3529 | 0.110 |
Why?
|
| Acrylamides | 1 | 2014 | 260 | 0.110 |
Why?
|
| Genes, Duplicate | 1 | 2012 | 30 | 0.100 |
Why?
|
| Somatostatin | 1 | 2014 | 447 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 6 | 2015 | 1705 | 0.100 |
Why?
|
| Optic Nerve Glioma | 1 | 2012 | 32 | 0.100 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 71 | 0.100 |
Why?
|
| Karnofsky Performance Status | 3 | 2019 | 165 | 0.100 |
Why?
|
| Decision Trees | 1 | 2014 | 506 | 0.100 |
Why?
|
| Models, Biological | 5 | 2021 | 9467 | 0.100 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2012 | 74 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.100 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2192 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 983 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 482 | 0.100 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2012 | 81 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 237 | 0.100 |
Why?
|
| Phenotype | 5 | 2020 | 16546 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2018 | 1479 | 0.100 |
Why?
|
| Glycine | 1 | 2015 | 662 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1342 | 0.100 |
Why?
|
| Reproducibility of Results | 10 | 2024 | 20080 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2015 | 547 | 0.100 |
Why?
|
| Mice, SCID | 4 | 2016 | 2627 | 0.100 |
Why?
|
| 3T3 Cells | 1 | 2013 | 1085 | 0.100 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 237 | 0.100 |
Why?
|
| Cluster Analysis | 6 | 2019 | 2698 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 282 | 0.090 |
Why?
|
| Phosphorylation | 7 | 2018 | 8313 | 0.090 |
Why?
|
| Cancer Vaccines | 1 | 2018 | 1046 | 0.090 |
Why?
|
| Combined Modality Therapy | 7 | 2020 | 8552 | 0.090 |
Why?
|
| Genotype | 6 | 2016 | 12960 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1268 | 0.090 |
Why?
|
| Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 346 | 0.090 |
Why?
|
| Lysine | 3 | 2020 | 1001 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2016 | 850 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 21025 | 0.090 |
Why?
|
| Multipotent Stem Cells | 2 | 2009 | 200 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 2 | 2012 | 560 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 2014 | 768 | 0.090 |
Why?
|
| Cell Line | 9 | 2019 | 15620 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 302 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2019 | 2618 | 0.090 |
Why?
|
| Predictive Value of Tests | 8 | 2021 | 15289 | 0.090 |
Why?
|
| HMGB Proteins | 2 | 2007 | 45 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3775 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2011 | 3442 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 358 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 2825 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1764 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.090 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 177 | 0.090 |
Why?
|
| Formaldehyde | 1 | 2011 | 358 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1120 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2022 | 3726 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 1423 | 0.080 |
Why?
|
| Diagnosis, Differential | 8 | 2018 | 12965 | 0.080 |
Why?
|
| Proteome | 1 | 2019 | 1855 | 0.080 |
Why?
|
| Dioxygenases | 1 | 2012 | 335 | 0.080 |
Why?
|
| Neuronavigation | 1 | 2011 | 164 | 0.080 |
Why?
|
| Autoantigens | 1 | 2014 | 877 | 0.080 |
Why?
|
| Base Sequence | 9 | 2014 | 12446 | 0.080 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 1837 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2018 | 2488 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 756 | 0.080 |
Why?
|
| Heat-Shock Response | 2 | 2023 | 179 | 0.080 |
Why?
|
| Receptor, TIE-2 | 2 | 2019 | 176 | 0.080 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 11903 | 0.080 |
Why?
|
| Mice, Knockout | 6 | 2020 | 14372 | 0.080 |
Why?
|
| CpG Islands | 1 | 2013 | 1221 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2362 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 1959 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2023 | 1895 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1728 | 0.080 |
Why?
|
| Histone Demethylases | 2 | 2023 | 323 | 0.080 |
Why?
|
| Microscopy | 1 | 2013 | 885 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.080 |
Why?
|
| Cytokines | 3 | 2019 | 7343 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2022 | 6189 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2022 | 311 | 0.070 |
Why?
|
| Pyrimidines | 3 | 2022 | 3016 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1599 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2313 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2018 | 2881 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 395 | 0.070 |
Why?
|
| Microvessels | 1 | 2012 | 572 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2012 | 716 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 3602 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 727 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 751 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 48 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1511 | 0.070 |
Why?
|
| Helix-Loop-Helix Motifs | 3 | 1996 | 96 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2016 | 17790 | 0.070 |
Why?
|
| Zebrafish | 2 | 2023 | 2997 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2017 | 12766 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 3 | 2010 | 2057 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2015 | 6068 | 0.070 |
Why?
|
| Drug Design | 1 | 2012 | 1061 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 951 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2020 | 10827 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 2640 | 0.070 |
Why?
|
| World Health Organization | 2 | 2023 | 1312 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 311 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2007 | 112 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2148 | 0.070 |
Why?
|
| Sirolimus | 1 | 2014 | 1547 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2024 | 14660 | 0.070 |
Why?
|
| Phospholipids | 1 | 2010 | 789 | 0.070 |
Why?
|
| Cell Movement | 1 | 2018 | 5206 | 0.070 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2008 | 184 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2023 | 2326 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 1529 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1634 | 0.070 |
Why?
|
| Time Factors | 6 | 2019 | 40165 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 942 | 0.070 |
Why?
|
| Ischemia | 1 | 2015 | 1893 | 0.070 |
Why?
|
| Methylation | 2 | 2020 | 1082 | 0.070 |
Why?
|
| HEK293 Cells | 4 | 2022 | 4264 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2007 | 313 | 0.070 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 1841 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1403 | 0.060 |
Why?
|
| Binding Sites | 4 | 2014 | 6048 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 476 | 0.060 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2005 | 24 | 0.060 |
Why?
|
| Quantum Dots | 1 | 2007 | 168 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3707 | 0.060 |
Why?
|
| Luciferases | 1 | 2007 | 716 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3696 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6551 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5305 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5870 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 3075 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2526 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 1613 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1084 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2012 | 1649 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 695 | 0.060 |
Why?
|
| Brain Abscess | 1 | 2005 | 120 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6029 | 0.060 |
Why?
|
| Piperazines | 3 | 2009 | 2525 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 858 | 0.060 |
Why?
|
| Radiography | 3 | 2014 | 6965 | 0.060 |
Why?
|
| Ectoderm | 1 | 2004 | 137 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 724 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 1055 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3527 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2009 | 719 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 351 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2015 | 5039 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2022 | 1755 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 17624 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 865 | 0.060 |
Why?
|
| Telomere | 2 | 2023 | 933 | 0.050 |
Why?
|
| Hyperargininemia | 1 | 2003 | 12 | 0.050 |
Why?
|
| Claudins | 1 | 2024 | 115 | 0.050 |
Why?
|
| Wnt1 Protein | 1 | 2003 | 120 | 0.050 |
Why?
|
| Endpoint Determination | 2 | 2017 | 597 | 0.050 |
Why?
|
| Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Galectin 1 | 1 | 2023 | 128 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2019 | 544 | 0.050 |
Why?
|
| Patient Selection | 1 | 2014 | 4283 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4938 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 8950 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2016 | 6568 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2002 | 84 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2024 | 814 | 0.050 |
Why?
|
| RNA Interference | 3 | 2019 | 2846 | 0.050 |
Why?
|
| Up-Regulation | 4 | 2019 | 4122 | 0.050 |
Why?
|
| Stereotaxic Techniques | 2 | 2016 | 549 | 0.050 |
Why?
|
| Gene Expression | 2 | 2014 | 7588 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1690 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 2 | 2018 | 877 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1952 | 0.050 |
Why?
|
| Mesoderm | 2 | 1995 | 672 | 0.050 |
Why?
|
| Computational Biology | 3 | 2020 | 3505 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2023 | 413 | 0.050 |
Why?
|
| Homozygote | 2 | 2023 | 1788 | 0.050 |
Why?
|
| Nervous System | 2 | 2022 | 543 | 0.050 |
Why?
|
| Brain Stem | 2 | 2017 | 857 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 1246 | 0.050 |
Why?
|
| Consensus | 2 | 2023 | 3113 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2014 | 3531 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2024 | 495 | 0.050 |
Why?
|
| International Agencies | 2 | 2012 | 244 | 0.050 |
Why?
|
| Neurofibromin 1 | 2 | 2012 | 190 | 0.050 |
Why?
|
| Protein Binding | 4 | 2014 | 9335 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 944 | 0.050 |
Why?
|
| Vaccinia virus | 1 | 2022 | 331 | 0.050 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 7593 | 0.050 |
Why?
|
| RNA | 2 | 2024 | 2722 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6498 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2006 | 865 | 0.050 |
Why?
|
| Genetic Markers | 3 | 2015 | 2608 | 0.050 |
Why?
|
| Lipids | 1 | 2011 | 3336 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 631 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2020 | 30 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2016 | 731 | 0.040 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 5799 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 6216 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2020 | 1513 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 1345 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 616 | 0.040 |
Why?
|
| Feedback | 1 | 2023 | 791 | 0.040 |
Why?
|
| Glutamine | 1 | 2003 | 576 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1019 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2056 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
| Transgenes | 1 | 2003 | 1006 | 0.040 |
Why?
|
| Melanoma | 1 | 2018 | 5697 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 877 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 81 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2023 | 616 | 0.040 |
Why?
|
| Equipment Design | 2 | 2018 | 3520 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 1415 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2024 | 26181 | 0.040 |
Why?
|
| Cranial Irradiation | 2 | 2015 | 391 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 995 | 0.040 |
Why?
|
| Biphenyl Compounds | 2 | 2014 | 992 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2018 | 2536 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2012 | 1155 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2020 | 54303 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2394 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2023 | 1493 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 333 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2023 | 2471 | 0.040 |
Why?
|
| Twins | 1 | 2020 | 339 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
| Propensity Score | 2 | 2017 | 1928 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9185 | 0.040 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 213 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2013 | 1955 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4024 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| S Phase | 1 | 2019 | 422 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 730 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 370 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2018 | 169 | 0.040 |
Why?
|
| DNA Repair | 2 | 2018 | 2039 | 0.040 |
Why?
|
| Proteomics | 2 | 2024 | 3817 | 0.040 |
Why?
|
| Diencephalon | 1 | 2017 | 54 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2019 | 317 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 587 | 0.040 |
Why?
|
| Frozen Sections | 2 | 2015 | 153 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2017 | 4048 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 293 | 0.040 |
Why?
|
| Regeneration | 1 | 2006 | 1506 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
| Necrosis | 2 | 2015 | 1612 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 834 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2024 | 2209 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 929 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2023 | 2025 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1131 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 542 | 0.040 |
Why?
|
| Stroke | 1 | 2019 | 9962 | 0.040 |
Why?
|
| Receptors, sigma | 1 | 2017 | 45 | 0.030 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2017 | 55 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12531 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2017 | 203 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2023 | 4090 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 623 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2017 | 122 | 0.030 |
Why?
|
| Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 705 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1407 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 2105 | 0.030 |
Why?
|
| Recurrence | 2 | 2019 | 8482 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 86 | 0.030 |
Why?
|
| Ependyma | 1 | 2016 | 56 | 0.030 |
Why?
|
| Pyridines | 3 | 2014 | 2879 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 558 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1428 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 2020 | 490 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6771 | 0.030 |
Why?
|
| Cell Count | 2 | 2012 | 1835 | 0.030 |
Why?
|
| Paraplegia | 1 | 2016 | 162 | 0.030 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2015 | 15 | 0.030 |
Why?
|
| Pyruvaldehyde | 1 | 2015 | 16 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2016 | 203 | 0.030 |
Why?
|
| Acetone | 1 | 2015 | 44 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 556 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 555 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2017 | 271 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2017 | 410 | 0.030 |
Why?
|
| Documentation | 1 | 2021 | 893 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2011 | 3105 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3738 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 791 | 0.030 |
Why?
|
| Chromatiaceae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3301 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 516 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2013 | 4625 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 330 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2014 | 73 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2895 | 0.030 |
Why?
|
| Histone Code | 1 | 2015 | 156 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 838 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 136 | 0.030 |
Why?
|
| Hematoxylin | 1 | 2013 | 60 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2013 | 69 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 3484 | 0.030 |
Why?
|
| Vertebrates | 1 | 1995 | 228 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 729 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 1262 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 656 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1647 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 1 | 2013 | 553 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2005 | 2782 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 2015 | 190 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
| Genome | 1 | 2021 | 1739 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 4550 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 358 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1765 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1765 | 0.030 |
Why?
|
| Myosins | 1 | 1994 | 405 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 867 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1859 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1871 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 402 | 0.030 |
Why?
|
| Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1810 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 3276 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2013 | 195 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 514 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2015 | 330 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 658 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 900 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 321 | 0.030 |
Why?
|
| Microspheres | 1 | 2015 | 787 | 0.030 |
Why?
|
| Color | 1 | 2013 | 298 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2222 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 1516 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2873 | 0.030 |
Why?
|
| Gene Library | 1 | 2015 | 1060 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 444 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 373 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1636 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 2221 | 0.020 |
Why?
|
| Cerebellum | 1 | 2019 | 1496 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2016 | 704 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 282 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6238 | 0.020 |
Why?
|
| Steroids | 1 | 2017 | 928 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 270 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2012 | 252 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2203 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18416 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 263 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 188 | 0.020 |
Why?
|
| Procarbazine | 1 | 2011 | 172 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2012 | 196 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 563 | 0.020 |
Why?
|
| Lomustine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 534 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 734 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4899 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 193 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2012 | 160 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 156 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 3150 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3725 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 480 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1122 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 924 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1351 | 0.020 |
Why?
|
| Larva | 1 | 2012 | 509 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Remission Induction | 1 | 2016 | 2392 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1869 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1454 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 372 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1677 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 13451 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1648 | 0.020 |
Why?
|
| Immunity | 1 | 2015 | 998 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 653 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6597 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2015 | 1354 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 841 | 0.020 |
Why?
|
| Vincristine | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 1843 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2388 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1043 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2012 | 580 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2007 | 1991 | 0.020 |
Why?
|
| Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 232 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2651 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2010 | 1543 | 0.020 |
Why?
|
| Osteogenesis | 1 | 1995 | 1271 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2128 | 0.020 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2008 | 83 | 0.020 |
Why?
|
| Sulfonamides | 2 | 2008 | 1977 | 0.020 |
Why?
|
| Doxycycline | 1 | 2010 | 341 | 0.020 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2009 | 117 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2010 | 749 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 602 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5201 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
| Endostatins | 1 | 2008 | 168 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1913 | 0.020 |
Why?
|
| Carcinoma, Embryonal | 1 | 2007 | 37 | 0.020 |
Why?
|
| Kidney | 2 | 2019 | 7064 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2008 | 193 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4035 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2275 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8651 | 0.020 |
Why?
|
| Homeostasis | 1 | 2018 | 3306 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 869 | 0.020 |
Why?
|
| Diverticulitis | 1 | 2010 | 182 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2852 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2601 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 255 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 792 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 1052 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1928 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7806 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2514 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3441 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2007 | 418 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2007 | 326 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22053 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 282 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1885 | 0.020 |
Why?
|
| Streptozocin | 1 | 2006 | 194 | 0.020 |
Why?
|
| Seminoma | 1 | 2007 | 134 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 122 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 590 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2554 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1753 | 0.020 |
Why?
|
| Microdissection | 1 | 2005 | 151 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3969 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 2897 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2819 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 1304 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4412 | 0.020 |
Why?
|
| Lectins | 1 | 2006 | 484 | 0.010 |
Why?
|
| Neutropenia | 1 | 2010 | 884 | 0.010 |
Why?
|
| Skin | 1 | 2018 | 4466 | 0.010 |
Why?
|
| Adipokines | 1 | 2006 | 311 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10344 | 0.010 |
Why?
|
| Species Specificity | 1 | 2009 | 2418 | 0.010 |
Why?
|
| Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2566 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2011 | 1504 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1737 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 516 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1369 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3486 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3426 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 329 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 2006 | 359 | 0.010 |
Why?
|
| Amino Acids, Basic | 1 | 2003 | 9 | 0.010 |
Why?
|
| United States | 3 | 2018 | 72461 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8158 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2007 | 567 | 0.010 |
Why?
|
| Survivors | 1 | 2014 | 2375 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2696 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5434 | 0.010 |
Why?
|
| DNA | 1 | 2017 | 7233 | 0.010 |
Why?
|
| Arginase | 1 | 2003 | 80 | 0.010 |
Why?
|
| Learning | 1 | 2012 | 1739 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1553 | 0.010 |
Why?
|
| Thalidomide | 1 | 2008 | 884 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3127 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1077 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 1131 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6315 | 0.010 |
Why?
|
| Motor Activity | 1 | 2012 | 2687 | 0.010 |
Why?
|
| Ammonia | 1 | 2003 | 236 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8555 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 192 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 1174 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5781 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2138 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 157 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2379 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12159 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2006 | 559 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1436 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4578 | 0.010 |
Why?
|
| Heart | 1 | 2014 | 4393 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2009 | 1758 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4902 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 2418 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3442 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4433 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 850 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 835 | 0.010 |
Why?
|
| Arginine | 1 | 2003 | 934 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10547 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 1741 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3586 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29749 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6465 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15687 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4193 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 1999 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74359 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1996 | 103 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1801 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1995 | 416 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 1763 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 763 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4169 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 7509 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4925 | 0.000 |
Why?
|